PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 1 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $380,166 | -1.5% | 123,031 | +43.4% | 0.00% | – |
| Q2 2023 | $386,069 | +7.8% | 85,793 | +36.5% | 0.00% | – |
| Q1 2023 | $358,251 | -6.9% | 62,851 | -1.4% | 0.00% | – |
| Q4 2022 | $384,875 | +7.5% | 63,721 | +17.9% | 0.00% | – |
| Q3 2022 | $358,000 | +8.5% | 54,052 | -14.5% | 0.00% | – |
| Q2 2022 | $330,000 | -37.0% | 63,200 | -16.8% | 0.00% | – |
| Q1 2022 | $524,000 | -50.6% | 75,930 | -10.8% | 0.00% | – |
| Q4 2021 | $1,060,000 | -59.6% | 85,137 | +1.4% | 0.00% | -100.0% |
| Q3 2021 | $2,625,000 | +26.2% | 83,985 | +15.6% | 0.00% | 0.0% |
| Q2 2021 | $2,080,000 | -35.7% | 72,623 | -2.7% | 0.00% | 0.0% |
| Q1 2021 | $3,236,000 | -34.1% | 74,668 | +8.9% | 0.00% | -50.0% |
| Q4 2020 | $4,907,000 | – | 68,568 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $313,740,000 | 3.45% |
| Baker Brothers Advisors | 10,123,824 | $316,370,000 | 1.39% |
| Logos Global Management LP | 400,000 | $12,500,000 | 0.90% |
| HHLR ADVISORS, LTD. | 583,333 | $18,229,000 | 0.24% |
| Rock Springs Capital Management LP | 362,359 | $11,324,000 | 0.24% |
| Virtus ETF Advisers LLC | 6,292 | $197,000 | 0.09% |
| FEDERATED HERMES, INC. | 408,100 | $12,753,000 | 0.02% |
| Virtu Financial LLC | 7,940 | $248,000 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 1,483,319 | $46,353,719,000 | 0.02% |
| FMR LLC | 7,055,666 | $220,489,000 | 0.02% |